A new era of treatment for elderly acute myeloid leukemia (AML) patients?
Hagop M. Kantarjian
What has changed in AML treatment in the last 30 years?
FLT3 inhibitors - their role in AML
Virus-specific T cells - effectiveness, safety profile and use
SPIRIT2 trial on dasatinib for AML - safety and side effect management